COMMUNIQUÉS West-GlobeNewswire

Full 12-Month Data from the ACCCESS U.S. Pivotal Study in Complete Concentric Collapse Patients Presented at ISSS 2026
15/10/2026
Full 12-Month Data from the ACCCESS U.S. Pivotal Study in Complete Concentric Collapse Patients Presented at ISSS 2026 Genio® bilateral stimulation delivered a 74.3% median reduction in AHI at 12 months, with no device [...]
Données Complètes à 12 Mois de l’Étude Pivot Américaine ACCCESS chez les Patients Atteints de Collapsus Concentrique Complet Présentées à l’ISSS 2026
15/10/2026
Données Complètes à 12 Mois de l’Étude Pivot Américaine ACCCESS chez les Patients Atteints de Collapsus Concentrique Complet Présentées à l’ISSS 2026 La stimulation bilatérale Genio® a permis une réduction médiane de 74 [...]
Syndax’s Revuforj® (revumenib) Named to TIME’s Best Inventions of 2026 List
15/10/2026
NEW YORK, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that Revuforj ® (revumenib), the [...]
Opus Genetics Presents Positive Clinical Data from OPGx-BEST1 and OPGx-LCA5 Gene Therapy Programs at Retina in Rio 2026
15/10/2026
OPGx-BEST1 showed improved retinal sensitivity in 75% of evaluable participants in the initial low-dose Cohort 1 of the Company’s Phase 1/2 clinical trial, supporting further clinical development New BEST1 data analyses [...]
MDxHealth Announces Preliminary Third Quarter 2026 Revenue and Suspends Full-Year 2026 Revenue Guidance
15/10/2026
IRVINE, CA – October 15, 2026 ( GlobeNewswire ) – MDxHealth SA (NASDAQ: MDXH) (the "Company" or "mdxhealth"), a leader in urology-focused precision diagnostics, today announced preliminary unaudited revenue from [...]
Anavex Receives FDA Clearance of its IND Application for Blarcamesine in Fragile X Syndrome
15/10/2026
Anavex now has open INDs in all three core indications: Alzheimer's disease, Rett syndrome, and Fragile X syndrome Phase 2a study will evaluate the safety, tolerability and pharmacokinetics of blarcamesine oral solution [...]
Avance Clinical to Showcase its Early Phase Center of Excellence Model at AusBiotech International 2026
15/10/2026
Australian-headquartered global CRO with more than 30 years of early phase experience to meet sponsors at Stand #72, Gold Coast, 21–23 October 2026 ADELAIDE, Australia, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Avance Clinical [...]
Digbi Health Brings Precision Biology Care to All 50 States With 700+ Clinicians and Coaches Through OpenLoop Health and MD Integrations
15/10/2026
More than 300 employers and health plans now offer a unified platform for metabolic, inflammatory, and hormonal care, built on each member’s gut microbiome, genetics, and glucose data, as a fully covered benefit [...]
Booking Health Announces Medical Records Review, Specialist Second Opinions and Treatment Coordination for Pancreatic Cancer Patients Seeking Care in Germany
15/10/2026
Langenfeld, Germany --, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Booking Health, a medical travel coordination service, announces medical records review, specialist second opinions and full treatment coordination for [...]
Spineway : NINE-MONTH REVENUE
15/10/2026
Press release / Ecully, October 15, 2026 – 6 p.m. NINE-MONTH REVENUE: €8 MILLION Continued structuring to optimize supply and support the growth strategy Appointment of Erwan Martin as Deputy Chief Executive Officer In [...]
SPINEWAY : CHIFFRE D’AFFAIRES À 9 MOIS
15/10/2026
Communiqué de presse / Ecully, le 15 octobre 2026 – 18h CHIFFRE D’AFFAIRES 9 MOIS : 8 M€ Poursuite de la structuration pour optimiser les approvisionnements et contribuer à la stratégie de développement Nomination d’ [...]
Revolution Medicines’ RASONQUE™ (daraxonrasib) Receives Positive CHMP Opinion Recommending Marketing Authorization in European Union for Metastatic Pancreatic Cancer
15/10/2026
Recommendation based on results from Phase 3 RASolute 302 trial, which demonstrated a 60% reduction in risk of death compared with chemotherapy in the overall study population with statistically significant and [...]
Nanox Selected as One of TIME’s Best Inventions of 2026 for its Nanox.ARC X
15/10/2026
Nanox.ARC X recognized among the “world’s most groundbreaking innovations” and for its approach to making advanced medical imaging more accessible Marks Nanox’s second appearance on TIME’s Best Inventions list, and its [...]
Progyny to Present New Menopause Research at The Menopause Society 2026 Annual Meeting
15/10/2026
NEW YORK, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, announced today that it will present new research evaluating real-world outcomes [...]
Akari Therapeutics CEO Highlights Differentiated ADC Payload Strategy and Path Toward Clinical Development in New CEO Corner
15/10/2026
CEO Abizer Gaslightwala discusses Akari’s novel PH1 payload strategy and execution priorities supporting AKTX-101’s advancement toward planned Phase 1 clinical development in mid-2027 Recent deal activity and emerging [...]
NeurAxis Announces Medical Policy Coverage Milestone, Expanding Access to 26 Million Additional Covered Lives
15/10/2026
Total national coverage footprint for PENFS increases to over 147 million covered lives CARMEL, Ind., Oct. 15, 2026 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis” or the “Company”) (NYSE American: NRXS), a medical [...]
Edesa Biotech Announces FDA IND Clearance for Phase 2 Vitiligo Study
15/10/2026
Enables expansion of ongoing vitiligo clinical study to U.S. investigational sites Topline data anticipated Q4 2027 TORONTO, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage [...]
Precision Neuroscience™ Appoints Nevro Founder Konstantinos Alataris as President and Katherine Neuenfeldt as Senior Vice President, Commercial Strategies
15/10/2026
NEW YORK, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Precision Neuroscience Corporation (Precision), a brain–computer interface (BCI) company, today announced that Konstantinos Alataris, Ph.D., founder and former chief executive [...]
Clever Care Health Plan Introduces Expanded 2027 Medicare Advantage Benefits Package to Enhance Strong Member Experience
15/10/2026
2027 benefits and new member-focused website build on the plan’s commitment to member trust and exceptional service HUNTINGTON BEACH, Calif., Oct. 15, 2026 (GLOBE NEWSWIRE) -- Clever Care Health Plan, a culturally [...]

Pages